Last reviewed · How we verify
NCT04531761: PSP
Evaluating the Efficacy of the Parent Support Program
NA trial testing Parent Support Program in Prejudice in 570 participants. Completed in 1 December 2021.
1 December 2021
Quick facts
| Lead sponsor | Palo Alto University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 570 |
| Start date | 27 September 2020 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Parent Support Program
Conditions studied
- Prejudice — all drugs for Prejudice →
- Gender Identity — all drugs for Gender Identity →
- Knowledge, Attitudes, Practice — all drugs for Knowledge, Attitudes, Practice →
Sponsor
Palo Alto University
Who can join
18 and older, any sex, with Prejudice or Gender Identity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the study is to evaluate the efficacy of an online intervention (the Parents Support Program) aimed at increasing supportive behaviors among parents of transgender youth. The intervention consists of three modules that include a variety engaging activities such as social perspective taking exercises, writing prompts, videos of parents, youth, and experts, and psycho-educational materials. The study uses an experimental design with a waitlist control. Both the experimental and control groups will complete a pre-test, one month follow up, and two month follow up survey. Targeted outcomes include knowledge about gender diversity, attitudes about trans youth, and supportive parenting behaviors.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04531761
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Palo Alto University trials
Trials by the same sponsor.
- NCT07437872 — Testing Mechanisms of Virtual Reality Exposure Therapy for Social Anxiety · NA · recruiting
- NCT07247149 — Testing a Novel Attention Based Training Prevention Strategy for First Responders: FirstFocus a Mobile App · NA · enrolling by invitation
- NCT06409247 — iExposure Intervention for Social Anxiety · NA · active not recruiting
- NCT06267313 — Attention Training for COVID-19 Related Distress · NA · terminated
- NCT04230668 — Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder and Borderline Personality Disorder (PTSD-BPD) · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04531761 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Palo Alto University
- Last refreshed: 8 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04531761.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing